ArticleJournal of chemical information and modeling2026
Automated Force Field Developer and Optimizer Platform: Torsion Reparameterization.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
General force fields such as General Amber Force Field (GAFF) have been designed for broad applicability and are widely used in protein-ligand binding simulations in structure-based drug discovery. However, the force field parameters are not always transferable across ligand molecules, and custom reparameterization is sometimes necessary for accurate binding free energy simulations. This is especially true for torsion parameters, which are highly dependent on stereoelectronic and steric effects. Here, we report a novel, flexible, and user-friendly computational tool called the Automated Force Field Developer and Optimizer (AFFDO) platform that allows generating accurate, tailored GAFF2 torsion parameters for drug-like molecules. For a given ligand, AFFDO selects the most important torsions, carries out GPU-accelerated density functional theory calculations to collect reference data and fits torsion terms using a fast gradient-based optimizer that leverages automated differentiation. We benchmark AFFDO by parametrizing a series of drug-like molecules and carrying out protein-ligand relative binding free energy (RBFE) simulations. The results show that AFFDO can significantly improve GAFF2 torsion parameters against QM reference data, which in some cases translates into better agreement with experimental RBFE values within a reasonable computational time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.